Solara Active Pharma Sciences Limited

BSE:541540 Stock Report

Market Cap: ₹36.6b

Solara Active Pharma Sciences Future Growth

Future criteria checks 4/6

Solara Active Pharma Sciences is forecast to grow earnings and revenue by 95.4% and 13.3% per annum respectively. EPS is expected to grow by 95.9% per annum. Return on equity is forecast to be 10.4% in 3 years.

Key information

95.4%

Earnings growth rate

95.9%

EPS growth rate

Pharmaceuticals earnings growth17.9%
Revenue growth rate13.3%
Future return on equity10.4%
Analyst coverage

Low

Last updated22 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BSE:541540 - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202717,9451,509N/A2,7841
3/31/202616,8051,559N/A2,7071
3/31/202515,3648552,1442,6441
9/30/202412,218-5,3618711,216N/A
6/30/202413,001-5,613N/AN/AN/A
3/31/202412,889-5,6746781,089N/A
12/31/202314,069-3,077N/AN/AN/A
9/30/202315,529-3255341,511N/A
6/30/202314,661-253N/AN/AN/A
3/31/202314,438-2224491,563N/A
12/31/202214,240-241N/AN/AN/A
9/30/202211,296-1,644-1,527-222N/A
6/30/202211,928-1,247N/AN/AN/A
3/31/202212,683-581-4,506-2,420N/A
12/31/202113,517-34N/AN/AN/A
9/30/202116,7812,023-3,236-953N/A
6/30/202116,7402,293N/AN/AN/A
3/31/202116,1692,214-1901,555N/A
12/31/202014,6941,826N/AN/AN/A
9/30/202013,8641,5812912,634N/A
6/30/202013,4001,304N/AN/AN/A
3/31/202013,2181,146-2672,422N/A
12/31/201914,1031,231N/AN/AN/A
9/30/201914,2281,0391,4942,839N/A
6/30/201914,140845N/AN/AN/A
3/31/201913,8676141,0731,663N/A
3/31/20185,21060N/A492N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 541540 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (6.7%).

Earnings vs Market: 541540 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 541540 is expected to become profitable in the next 3 years.

Revenue vs Market: 541540's revenue (13.3% per year) is forecast to grow faster than the Indian market (10.6% per year).

High Growth Revenue: 541540's revenue (13.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 541540's Return on Equity is forecast to be low in 3 years time (10.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y